The company was cleared to manufacture and market a once-weekly injectable treatment for adults whose type 2 diabetes is not adequately controlled
Asterisks indicate hyphal movement to adjacent rice cells
oral daily (Rybelsus) Tirzepatide Weekly injection (Mounjaro/Zepbound) Trial weight loss Tesofensine About 10% at 0.5 mg over 24 weeks (Phase 2 and Phase 3) Semaglutide About 15% over 68 weeks (STEP trials) Tirzepatide About 21% over 72 weeks (SURMOUNT trials) FDA status (June 2026) Tesofensine Not approved for any indication Semaglutide Approved (Wegovy for obesity, Ozempic for type 2 diabetes) Tirzepatide Approved (Zepbound for obesity, Mounjaro for type 2 diabetes) Main safety concern Tesofensine Heart rate rise, insomnia, mood Semaglutide Nausea, GI upset, rare pancreatitis Tirzepatide Nausea, GI upset, rare pancreatitis Direct head-to-head trials between tesofensine and GLP-1 drugs have not been run
Does semaglutide cause BOTOX or dermal fillers to wear off faster
The result is a holistic boost to your well-being
The B12 enters your bloodstream within 30 minutes and begins supporting cellular energy production immediately
